243 related articles for article (PubMed ID: 2418955)
1. Identification of a Mr 40,000 polypeptide from colorectal cancer which expresses organ-specific cancer neoantigen activity as determined by leukocyte adherence inhibition.
Artigas C; Thomson DM; Durko M; Sutherland M; Scanzano R; Shenouda G; Dubois AE
Cancer Res; 1986 Apr; 46(4 Pt 1):1874-81. PubMed ID: 2418955
[TBL] [Abstract][Full Text] [Related]
2. An isolated enriched organ-specific cancer neoantigen of human lung cancer for leukocyte adherence inhibition assays.
Dubois AE; Thomson DM; Sutherland ME; Scanzano R
Cancer Res; 1985 Jun; 45(6):2661-9. PubMed ID: 3886136
[TBL] [Abstract][Full Text] [Related]
3. Organ specific neoantigens reactive in the leukocyte adherence inhibition assay: affinity purification of human colon carcinoma antigen and its cross-reactive protein using monoclonal antibodies.
Hadas E; Fink A; Gembom E; Harpaz N; Shani A; Bentwich Z; Eshhar Z
Cancer Res; 1986 Oct; 46(10):5201-5. PubMed ID: 2428475
[TBL] [Abstract][Full Text] [Related]
4. The isolation of colon cancer organ specific neoantigen by the use of the leukocyte adherence inhibition assay and monoclonal antibodies.
Fink A; Harpaz N; Weisman Z; Shani A; Bentwich Z
Anticancer Res; 1986; 6(4):813-7. PubMed ID: 3752960
[TBL] [Abstract][Full Text] [Related]
5. Recognition of a purified Mr-40,000 organ-specific immunogen of human lung cancer by class II-restricted T-cells.
Thomson DM; Sutherland M; Scanzano R; Shenouda G
J Natl Cancer Inst; 1987 Oct; 79(4):653-61. PubMed ID: 2443737
[TBL] [Abstract][Full Text] [Related]
6. Extraction of human organ-specific cancer neoantigens from cancer cells and plasma membranes with 1-butanol.
Labateya N; Thomson DM; Durko M; Shenouda G; Robb L; Scanzano R
Cancer Res; 1987 Feb; 47(4):1058-64. PubMed ID: 3100029
[TBL] [Abstract][Full Text] [Related]
7. Purification from a human lung cancer cell line of a water soluble molecule mediating leukocyte adherence inhibition for patients with lung cancer.
Thomson DM; Sutherland M; Durko M; Dubois T; Scanzano R; Labateya N; Shenouda G
Int J Cancer; 1985 Jun; 35(6):707-14. PubMed ID: 4008098
[TBL] [Abstract][Full Text] [Related]
8. Anti-tumor immunity in breast cancer evaluated by a computerized tube leukocyte adherence inhibition (LAI) assay.
Fink A; Shani A; Feldman B; Wechsler U; Pfeffermann R; Eliraz A; Offer S; Harpaz N; Bentwich Z
Eur J Surg Oncol; 1989 Feb; 15(1):17-9. PubMed ID: 2645173
[TBL] [Abstract][Full Text] [Related]
9. Demonstration of tube leukocyte adherence inhibition assay with coded samples of blood.
Thomson DM
Cancer Res; 1979 Feb; 39(2 Pt 2):627-9. PubMed ID: 83917
[TBL] [Abstract][Full Text] [Related]
10. Leukocyte adherence inhibition: tumor specificity of cellular and serum-blocking reactions in human melanoma, breast cancer, and colorectal cancer.
Halliday WJ; Koppi TA; Khan JM; Davis NC
J Natl Cancer Inst; 1980 Aug; 65(2):327-35. PubMed ID: 6157045
[TBL] [Abstract][Full Text] [Related]
11. New monoclonal antibodies against colon cancer-associated antigens.
Drewinko B; Yang LY; Chan J; Trujillo JM
Cancer Res; 1986 Oct; 46(10):5137-43. PubMed ID: 2428473
[TBL] [Abstract][Full Text] [Related]
12. Identification of a human cancer related organ-specific neoantigen.
Ilantzis C; Thomson DM; Michaelidou A; Benchimol S; Stanners CP
Microbiol Immunol; 1993; 37(2):119-28. PubMed ID: 7684807
[TBL] [Abstract][Full Text] [Related]
13. [Preparation and characterization of human colon tumor-associated antigen and its clinical significance].
Liu XY; Yao XL; Song Y; Liu XY; Zhang P; Xu ZS; Song LH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Apr; 23(4):335-7. PubMed ID: 17428389
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of leukocyte adherence by 3-M potassium chloride extracts of human colorectal tumors.
Ichiki AT; Quirin YP; Collmann IR; Sonoda T; Krauss S
J Natl Cancer Inst; 1980 Mar; 64(3):419-23. PubMed ID: 6986496
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a mouse/human chimeric monoclonal antibody (17-1A) to a colon cancer tumor-associated antigen.
Shaw DR; Khazaeli MB; Sun LK; Ghrayeb J; Daddona PE; McKinney S; LoBuglio AF
J Immunol; 1987 Jun; 138(12):4534-8. PubMed ID: 3584980
[TBL] [Abstract][Full Text] [Related]
16. Her-2/neu-derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytes.
Brossart P; Stuhler G; Flad T; Stevanovic S; Rammensee HG; Kanz L; Brugger W
Cancer Res; 1998 Feb; 58(4):732-6. PubMed ID: 9485028
[TBL] [Abstract][Full Text] [Related]
17. Partial purification of organ-specific neoantigens from human colon and breast cancer by affinity chromatography with human tumour-specific gamma-globulin.
Thomson DM; Tataryn DN; Schwartz R
Br J Cancer; 1980 Jan; 41(1):86-99. PubMed ID: 7362781
[TBL] [Abstract][Full Text] [Related]
18. An evaluation of leukocyte adherence inhibition in the immunodiagnosis of colorectal cancer.
Halliday WJ; Maluish AE; Stephenson PM; Davis NC
Cancer Res; 1977 Jul; 37(7 Pt 1):1962-71. PubMed ID: 67885
[TBL] [Abstract][Full Text] [Related]
19. Hemocytometer leukocyte adherence inhibition technique.
Maluish AE; Halliday WJ
Cancer Res; 1979 Feb; 39(2 Pt 2):625-6. PubMed ID: 83916
[TBL] [Abstract][Full Text] [Related]
20. Cell surface glycoprotein associated with human lung tumors that is similar to but distinct from the epidermal growth factor receptor.
Chen FA; Repasky EA; Takita H; Schepart BS; Bankert RB
Cancer Res; 1989 Jul; 49(13):3642-9. PubMed ID: 2659165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]